The Board of Directors of Suzhou Fushilai Pharmaceutical Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.5 CNY | +2.57% | +5.20% | -21.00% |
1st Jan change | Capi. | |
---|---|---|
-21.00% | 322M | |
+54.25% | 823B | |
+42.31% | 641B | |
-6.69% | 352B | |
+16.84% | 324B | |
+8.17% | 301B | |
+14.04% | 241B | |
+1.88% | 223B | |
+13.43% | 218B | |
+7.52% | 167B |
- Stock Market
- Equities
- 301258 Stock
- News Suzhou Fushilai Pharmaceutical Co., Ltd.
- Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.